Gw Pharma ADR (GWPH)
$104.46 2.54 (2.37%)
19:01 EST GWPH Stock Quote Delayed 15 Minutes
Previous Close $104.46
Market Cap 2.95B
PE Ratio -
Volume (Avg. Vol.) 1.03M
Day's Range 99.10 - 107.46
52-Week Range 95.71 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
Medical cannabis’ cheap costs and natural uses will benefit GW Pharmaceuticals stock in the long run, keeping GWPH stock growing.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
GW Pharmaceutical reported its quarterly earnings results late on Tuesday, bringing in revenue that was thrice the amount it was a year ago.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Like most cannabis stocks, GW Pharmaceuticals has become unpredictable, but reading one key chart indicator could help investor profit in GWPH stock.
Looking for stocks to buy before the Santa Claus rally? These 5 'Strong Buy' stocks have the backing of Wall Street's top analysts
GW Pharmaceuticals (GWPH) stock is down more than 5% as the company's fourth-quarter revenue came in below what analysts were projecting.
There was good news for marijuana stocks today after GW Phamaceuticals (GWPH) announced recent results from a late-stage study.
The future of marijuana stocks is a viable concept, as legalization will increase the use of pot and millions more potential users will try it.
Marijuana stocks like Cronos, Cannabis Sativa and Canopy Growth are just a handful of the names worth a closer look here.
New Age Beverages stock got a bit of a boost on Friday as the company prepares to launch its upcoming CBD drinks in select states.
GW Pharmaceuticals stock was on the rise Thursday following news of its epilepsy drug Epidiolex getting a Class V rating.
GWPH stock was up over 2.7% as the DEA is set to reclassify Epidiolex (cannabidiol) to be allowed for medicinal use in the coming months.
When looking at marijuana stocks, it's important to remember that how you play a big sector rally matters most. Here's what you need to know about stocks based in the cannabis space.
According to Wall Street, these 7 stellar strong buy stock picks all boast over 30% upside potential from their current prices.
The cannabis market has $100 billion-plus potential, but cannabis stocks won't start to realize that potential until a few years down the road.
GW Pharmaceuticals (GWPH) stock remained unchanged after hours on Tuesday despite the company posted a loss that was wider than it was in the year-ago quarter.
For those unfamiliar with Dravet syndrome, it’s a rare genetic condition that hits newborns and results in seizures caused by fever and involuntary muscle spasms. Young children who develop this condition tend to experience difficulty speaking, reduced motor skills, and hyperactivity.
Navellier RatingsPowered by Portfolio Grader